NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 2.71% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 2.52% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 2.50% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 2.33% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 2.22% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.19% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.15% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.13% |
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 2.09% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.02% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.95% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.93% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 1.88% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.87% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.85% |